Markets
BSE See NSE See 39,046.34
85.55 (0.22%)
collapse Related Readings collapse

Better Than Expected

| 11/29/2012 9:04 PM Thursday

It feels good when expectations are met. But that, of course, also depends on what you expect. Take for instance, the expectations that we have from our policy makers today. While we wait for all the talk to translate into action on the reforms front, there is hardly any tangible move that has happened until now. Even as I key in this edit, news reports are suggesting that some action could be expected on this front in the next week. Let’s hope for the best, as a lot of it would shape the future direction that the markets would take.

The reason why I began by saying that it feels good when expectations are met is the fairly decent, or rather the good performance that Corporate India has put up during the September 2012 quarter. Quarterly results have always been that one crucial trigger for the markets. Expectations, good or bad, about corporate performance have shaped the way that the equity markets behave. A performance in sync with expectations tends to bode well for the markets, and the same applies vice versa. In fact, it is not just the past performance but also the future trends that go a long way in aiding objective investment decision making.

So, how did corporate India fare in the quarter that went by? Was its performance good, bad or ugly, and more so, what can we expect going forward? In this issue, our editorial and research team has incisively analysed the performance of India Inc. for the September quarter for the benefit of our readers. The cover story (Pg 11) provides all the necessary answers to the questions above.

Despite all the odds that it faced, India Inc. has put up a rather good show during the September quarter of 2012. The topline growth for the 2125 companies that our team has looked at (we have considered only BSE ‘A’ and ‘B’ Group companies for the purpose of this study) stood at 9.85 per cent. Growth at the bottomline level came in at 8.41 per cent. This is certainly an improvement over the performance seen during the preceding quarter. Remember, for the June quarter of 2012, topline growth came in at over 12 per cent while the bottomline was up only 2.24 percent. This is certainly good, but what is more interesting is that it is far better than what was expected. While the economy (global as well as domestic) continues to face headwinds, this performance suggests that investors can look forward to better times ahead.

Indian pharma companies have done well following the patent expiry regime in the US. Frontline pharma companies have emerged as clear winners, thanks to their rigorous R&D approach. We are recommending one such company – Glenmark Pharma as our Choice Scrip (Pg 8) in this issue. Adding this fast growing and aggressively managed pharma company to your portfolio makes perfect sense. Read on to find out why.

When my team came up with the idea of recommending the stock of an engineering company which is in the business of completing a vehicle by building a body atop the chassis, it did not seem convincing at first. But a look at the fundamentals of Commercial Engineers and Body Builders Company (CEBBCO) threw up some very compelling reasons why we thought investors should look at picking up this stock for their portfolio. This scrip is our choice for the Low Priced Scrip (Pg 10) in this issue.

Our special report in the mutual funds section (Pg 68) tells you how to manage your risks while investing in mutual fund schemes by explaining the various parameters that are a perfect measure of risk. Investors should read the mind of fund managers and learn to think the way professional money managers do.

As always, there are a whole lot of our regular sections which complete this issue. Do let me know your thoughts on the content and help us improve upon our offering to you. After all, your perspective does matter to us. With that, I will sign off and leave you with the interesting investment ideas that our team has come up with. I hope that you do build wealth based on them.

 

Find More Articles on: DSIJ Magazine, Editorial

news letter

More for the early bird.

Get the post-market reports and breakfast news right in your inbox. See latest »

DSIJ Mindshare

MIDHANI and HAL partner to develop bio implants

Geyatee Deshpande / Article rating: 5.0

Mishra Dhatu Nigam Limited (MIDHANI) signs an MoU with Hindustan Antibiotics Limited (HAL). This MoU will provide synergy for quality manufacturing of MIDHANI’s Bio-medical Implants and get access to the pan-India distribution of HAL. This partnership is aimed to gain advantage from the strengths of both the companies and benefit users of Bio-medical products in India.

12345678910Last

Tiger Logistics topline to grow by 10%--buoyant over infra sector status to logistics sector

Tiger Logistics topline to grow by 10%--buoyant over infra sector status to logistics sector

Logistics sector will play a vital role in making the concept of ‘Make in India’ a success. This will be further aided by some of the recent steps taken by Government of India such as granting of infra sector status to logistics sector.

Best and worst Performing Sector Funds of Year 2017

Best and worst Performing Sector Funds of Year 2017

As the year-end has approached most of you are eager to know the mutual fund movers and shakers of the year 2017. Read on to find the performance of various sector dedicated funds.

Markets may start positive, but volatility likely due to F&O expiry

Markets may start positive, but volatility likely due to F&O expiry

The start of the F&O expiry day is likely to be in the green, but volatility may creep in with the progress of the session. The SGX Nifty suggests that the Nifty could open at 10,525 with gains of 32 points at the opening bell. 

Pidilite announces buyback of Rs 500 crore

Pidilite announces buyback of Rs 500 crore

The buyback offer comprises purchase of up to 50,00,000 equity shares. The buyback offer size comprises 0.975 per cent of the total paid-up equity capital of the company.

Bank Nifty drags markets to close in the red

Bank Nifty drags markets to close in the red

The late session fall in Bank Nifty changed the direction of the market, leading to a marginal fall in the benchmark indices. Bank Nifty yet again resisted at its multiple point downward sloping trendline level at 25733.

Six major underperforming MF schemes having higher expense ratios

Six major underperforming MF schemes having higher expense ratios

Mutual funds with a large size of assets under management (AUMs) are supposed to have lower expense ratios. However, there are schemes with large AUMs but having higher expense ratios and generating lower returns. 

Nifty Pharma supports market; Sun Pharma at bullish reversal

Nifty Pharma supports market; Sun Pharma at bullish reversal

Nifty Pharma index has come in as the healer in an otherwise sluggish market. Index has given a consolidation breakout at the 9420 level today and if the it sustains 9420, followed by 9628 on the upside, it has a long way to go.

Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Following stocks are close to their 52-week low as at 12.35 p.m. on December 27.

Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

The markets on December 27 opened gap down. BSE Sensex is trading at 34,068.15, up by 57.54 points and the Nifty is trading at 10,539.45, up by 7.95 points.

Five stocks with selling interest

Five stocks with selling interest

Overall volumes in futures & options currently stand at 62.75 lakh contracts with a turnover of Rs. 5,19,204.72 crore.